mars 2025

We are thrilled to announce our participation in the 13th Alzheimer’s & Parkinson’s Drug Development Summit as a solution provider and preclinical CRO expert in AD's and PD's disease studies. This summit is a unique opportunity to unite new faces across biotech and pharma, capitalize on groundbreaking progress, and accelerate the development of transformative neurodegenerative therapies. 📅 If you're attending the conference, book a meeting with Jérome BERNARD who will be in Boston all the week by clicking here. Let'discover ETAP-Lab's dedicated